Home/ Stocks/ PALI

Palisade Bio, Inc. Common Stock

PALI XNAS

$1.80 -0.18 (-9.05%) ▼ 15-min delayed

Open

$1.98

High

$1.99

Low

$1.80

Volume

3.04M

Market Cap

$301.72M

About Palisade Bio, Inc. Common Stock

Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.

Sector: BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) Employees: 14 Website →

Key Financials

Period	Revenue	Net Income	EPS
TTM 2025	$0	$-16,781,000	$-0.30
FY 2025	$0	$-16,781,000	$-0.30
Q3 2025	$0	$-2,868,000	$-0.38
Q2 2025	$0	$-2,784,000	$-0.58

Related Market News

No specific coverage for PALI yet. Check out our latest market news or earnings calendar.

Get PALI Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Palisade Bio, Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.